Skip to Main Content

NKGN logo

NKGen Biotech, Inc. Common Stock

N/A USD
N/A
N/A
...
Chart
Financials
Description
NKGN Company Description

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

NKGN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NKGN Smart Score

Score Breakdown
NKGN Company Description

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity. Show Less

Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of NKGN by members of U.S. Congress

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login

Recently reported changes by institutional investors

Quiver Logo

Sign Up for Access

Sign Up or Login

Quarterly net insider trading by NKGN's directors and management

Quiver Logo

Sign Up for Access

Sign Up or Login

Government lobbying spending instances

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
U.S. Patents

New patents grants

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Government Contracts

Federal grants, loans, and purchases

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
WallStreetBets

Number of mentions of NKGN in WallStreetBets Daily Discussion

Quiver Logo

Sign Up for Access

Sign Up or Login
NKGN News

Recent insights relating to NKGN

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
CNBC Recommendations

Recent picks made for NKGN stock on CNBC

  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Top ETF Holders

ETFs with the largest estimated holdings in NKGN

  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Corporate Flights

Flights by private jets registered to NKGN

  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Back To Top